[Use of esophageal investigation in the mid-term outcome after radiofrequency ablation of intranodal reentrant tachycardia].
The aim of this prospective study was to assess the medium term results of radio-frequency ablation of intranodal tachycardias by transoesophageal stimulation and recordings. Transoesophageal stimulation was performed on average 9 months after ablation. The anterograde Wenckebach point, the presence of dual nodal conduction and inducibility of nodal tachycardias were determined under basal conditions and after isoproterenol. The follow-up period after ablation was 16.1 +/- 10.2 months. At the time of the oesophageal investigation 25 patients were asymptomatic and 5 had a recurrence of palpitations. The investigation was carried out without complications in all patients and lasted 34.8 +/- 14 minutes. The anterograde Wenckebach point was 340 +/- 78.2 ms and was unchanged compared with the value recorded by endocavitary left atrial stimulation before ablation (332 +/- 63.2 ms). Dual nodal conduction was observed in 19 patients. Nodal tachycardia was inducible in only 2 of the 5 patients with palpitations. Of the asymptomatic patients, 3 had inducible nodal tachycardias after isoproterenol. The authors conclude that oesophageal electrophysiological studies are a simple means of assessing the medium-term results of radiofrequency ablation of intranodal tachycardias. In those patients with a recurrence of symptoms but without documented arrhythmias, failure of radiofrequency ablation may be identified. In addition, the possibility of inducing nodal tachycardias in asymptomatic patients may be detected.
Deharo
J C
JC
Service de cardiologie, hôpital Sainte-Marguerite, CHU Marseille.
Moustaghfir
A
A
Macaluso
G
G
Le Tallec
L
L
Djiane
P
P
D000328:Adult; D002304:Cardiac Pacing, Artificial / Q000379:methods*; D017115:Catheter Ablation; D004947:Esophagus; D005260:Female; D005500:Follow-Up Studies; D006329:Heart Conduction System / Q000503:physiopathology / Q000601:surgery*; D006801:Humans; D007545:Isoproterenol; D008297:Male; D008875:Middle Aged; D011237:Predictive Value of Tests; D011446:Prospective Studies; D012008:Recurrence; D013566:Sympathomimetics; D013615:Tachycardia, Sinoatrial Nodal Reentry / Q000503:physiopathology / Q000601:surgery*; D016896:Treatment Outcome
D013566:Sympathomimetics; D007545:Isoproterenol
Utilisation de l'exploration oesophagienne pour le suivi à moyen terme après ablation par radiofréquence des tachycardies par réentrée intranodale.